Abstracts

Spatial Clustering of HIV Viremia Among People Who Inject Drugs (PWID) in India

Background: While India has made significant progress in engaging people on antiretroviral therapy (ART), people who inject drugs (PWID) living with HIV (PLWH) remain under-engaged in treatment with only ~26% on ART and 32% virally suppressed. Using geospatial data to identify geographical clusters of viremia could help find optimal locations to intervene. Methods: Respondent-driven sampling…

DNA Methylation Signatures of Inflammation in Youth Living With Perinatally-Acquired HIV

Background: Epigenetic modifications may highlight mechanisms through which HIV and antiretroviral therapy (ART) exposure during critical developmental periods affect biological pathways and disease risk. We examined if perinatally-acquired HIV is associated with genome-wide alterations in the DNA methylome by comparing youth living with perinatal HIV (YPHIV) and youth who are perinatally HIV-exposed uninfected (YPHEU) at…

Sex Differences in Growth Trajectories Between Early-Treated Infants With HIV and Controls

Background: Perinatally-acquired HIV infection is associated with increased risk of postnatal growth deficits which are only partially corrected with antiretroviral therapy (ART). Studies of sex differences in immune recovery and virologic response to ART among infants with perinatally acquired HIV (IHIV) have reported conflicting results. Here we investigate the role of sex in modifying the…

Resistance in Young Children Newly-Diagnosed With HIV in Western Cape, South Africa

Background: Pretreatment drug resistance among children living with HIV (CLHIV) can potentially compromise antiretroviral therapy (ART) effectiveness. Drug resistant HIV may be directly transmitted during vertical acquisition or resistance may be acquired in infants with HIV following exposure to antiretrovirals consumed through breastfeeding or administered as prophylaxis. Methods: We performed resistance testing in young CLHIV…

Predictive Markers for Sustained Viral Suppression on Dual bNAbs During ART Interruption in Children

Background: Phenotyping to identify susceptibility to broadly neutralizing antibodies (bNAbs) is costly and logistically challenging, and simple clinical markers to predict bNAb treatment success for children are needed. The combination of a negative qualitative HIV DNA and negative enzyme immunosorbent assay (EIA) at study entry was previously reported to correlate with success in the Tatelo…

Cancer Incidence in Children Who Are HIV-Exposed and Uninfected in England: Data Linkage Study

Background: Children born to women living with HIV develop in an in utero environment that includes exposure to HIV and antiretroviral therapy (ART). However, the long-term health implications of these exposures for children who are HIV-exposed and uninfected (CHEU) are largely unknown. Methods: Population-based surveillance data from children born to women living with HIV in…

Population Pharmacokinetics of ABC/DTG/3TC FDC to Support Dosing in Peds With HIV-1: IMPAACT 2019

Background: Once-daily fixed-dose combinations (FDC) containing abacavir (ABC), dolutegravir (DTG), and lamivudine (3TC) have been approved in the US for adults and children with HIV weighing ≥6 kg (Dispersible tablet (DT) and Tablets). This analysis assessed the ability of previously developed ABC, DTG, and 3TC pediatric population pharmacokinetic (PopPK) models using multiple formulations to describe…